Pediatric cutaneous mucocutaneous lymph node syndrome, also known as Kawasaki disease, tends to involve the cardiovascular system and requires prompt treatment to improve prognosis.
Pediatric cutaneous mucocutaneous lymph node syndrome is an acute systemic vasculitis disease that occurs in children under 5 years of age, and the main symptoms include fever, conjunctivitis, inflammatory damage to the lips and oral mucosa, skin erythema multiforme and scarlet fever-like rashes, pericarditis, endocarditis, etc., and even complicated by shock. Prompt treatment is required.
Treatment should first control inflammation, reduce cardiac damage, often use aspirin anti-inflammatory, gammaglobulin to reduce the incidence of coronary artery disease, etc. After regular treatment, most children have a good prognosis.
Therefore, once a child is clearly diagnosed with Kawasaki disease, parents need to actively cooperate with the treatment to avoid adverse consequences. The above drugs need to be used in accordance with medical advice.